ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Clinical trials for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested for Hard-to-Treat bowel disease
Disease control Recruiting nowThis study is testing an experimental tablet called HRS-7085 for adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. Researchers will compare the pill to a placebo (inactive tablet) in 66 participants to see if it reduces symptoms and is safe.…
Matched conditions: ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 06:51 UTC
-
New drug trial offers hope for Tough-to-Treat bowel disease
Disease control Recruiting nowThis study is testing an experimental drug called SHR-1139 in adults with moderate-to-severe ulcerative colitis, a chronic inflammatory bowel disease. It aims to see if the drug can reduce symptoms and improve gut healing over a 60-week period. The trial is for people who haven't…
Matched conditions: ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC